Why is Remus Pharma. falling/rising?

As of 22-Sep, Remus Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 798.50, which reflects a decrease of Rs 2.7 or 0.34%. The stock has underperformed significantly over various periods, with a 1-week decline of 2.62% and a 1-month drop of 15.27%. Additionally, it is trading lower than its moving averages across multiple time frames, indicating a bearish trend. The stock is also close to its 52-week low, being only 2.94% away from Rs 775. Furthermore, there has been a notable decrease in investor participation, with delivery volume falling by 31.03% against the 5-day average, suggesting reduced interest in the stock.
In the broader market context, the Sensex has shown resilience with a 1-week gain of 0.53% and a 1-month increase of 1.34%, contrasting sharply with Remus Pharmaceuticals' performance. This divergence highlights the stock's struggles relative to the overall market, as it has significantly lagged behind the benchmark, with a year-to-date decline of 36.06% compared to the Sensex's gain of 6.59%. The lack of available positive factors further compounds the challenges facing Remus Pharmaceuticals, as there are no indicators suggesting a turnaround in sentiment or performance.